Flow cytometry and immunofluorescence were used to verify that tumor cell-specific PD-L1 expression within UMSCC-1 tumors was increased following treatment with PD-L1 CAR haNKs (Figure 6—figure supplement 1A&B). Here, CD274 is linked to neoplasm.